1. What does the term "Advertise" mean under Schedule-II?
2. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
3. What is the main duty of a Federal Inspector?
4. What is the purpose of the license to manufacture drugs for experimental purposes?
5. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
6. The Authority may open its accounts with:
7. What condition must be met for an application for renewal of a licence to be entertained?
8. What labeling requirements apply to drugs manufactured for experimental purposes?
9. What does an Inspector require from a person during a search or seizure under Schedule-V?
10. The Authority shall levy and collect fees for its functions at rates determined by:
11. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
12. Who shall not be liable for a contravention of Section 23 of the Drugs Act 1976?
13. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
14. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
15. When does an Inspector need to divide a sample into three portoons instead of four?
16. What ethical criteria should be followed for medical drug promotion?
17. What is the primary purpose of the Committee of Experts on Drug Research?
18. What is the purpose of Form 6?
19. What type of containers are ophthalmic solutions and suspensions required to be contained in?
20. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
21. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
22. According to the schedule in the Drugs (Specifications) Rules, what specifications should drugs bear that reference publications specified under sub-clause (ii) of clause (z) of Section 3?
23. In case an exporter's license is suspended or canceled, what recourse does the licensee have?
24. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
25. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
26. What does the term "Advertise" mean under Schedule-II?
27. In what situations can a drug or substance be advertised to the medical, pharmaceutical, and allied professions without referring to the Federal Government?
28. What is the duration of a license to import drugs, unless suspended or canceled?
29. What is the primary function of the Federal Drug Laboratory as stated in the rules?
30. What is the penalty for a person who fails to provide information requested by the Authority?
31. What is the meaning of "sponsor" in the context of the Drugs (Research) Rules?
32. What is the fee for submitting an appeal to the Appellate Board, as mentioned in the rules?
33. What is the definition of "Biological Drugs (Ready-to-fill form)" under Schedule-I?
34. What is the maximum allowable retailer's discount for drugs?
35. Which power of the Inspector requires specific authorization by the Government?
36. What are "Medical Devices" under Schedule-I?
37. Within what time frame should the Authority submit its annual report to the Federal Government?
38. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
39. In which circumstances may the Registration Board register a drug on its own motion?
40. What is the purpose of an "airlock" in pharmaceutical manufacturing?
41. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
42. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
43. Which of the following is NOT a source of financing the Drug Regulatory Authority Fund?
44. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
45. What is the purpose of the Committee on Drugs Evaluation?
46. What action should the Authority take in response to objections raised by the Auditor-General?
47. What is the purpose of Schedule-III of the DRAP Act?
48. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
49. What information should be included in the written contract between the contract giver and contract acceptor for contract manufacture?
50. Which power of the Inspector requires specific authorization by the Government?
51. In which situations may the Registration Board provisionally register a drug for a period of two years?
52. For veterinary drugs, what is the source of specifications if they are not approved by the Registration Board?
53. What is the duration of a license to export drugs?
54. Which type of ophthalmic preparations is allowed to have a preservative?
55. What is the commencement date for the Drugs (Specifications) Rules, 1978?
56. What is the purpose of an "airlock" in pharmaceutical manufacturing?
57. The Central Research Fund fee collected by the Authority will be utilized for:
58. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
59. Which of the following offenses punishable under Schedule-III is non-cognizable?
60. For drugs other than those falling under specific categories, whose approval is required for the specifications?
61. What are "Medicated Cosmetics" under Schedule-I?
62. The Drugs Act, 1976 extends to which of the following areas?
63. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
64. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
65. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
66. What substances are NOT included in the definition of "Drug" under Schedule-I?
67. What is the role of the Quality Control Department in the manufacturing process?
68. Who is responsible for maintaining records of quarterly production and disposal of a drug?
69. In what circumstances shall a drug not be deemed misbranded or adulterated?
70. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
71. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
72. Which term refers to the set of operations that establish the relationship between values indicated by an instrument and known reference standards?
73. What is the purpose of the Drugs (Research) Rules, 1978?
74. What is the Appellate Board's authority to call for the record of a case for review?
75. Which authority may authorize a Federal Inspector to disclose information acquired during official duties?
76. What degree qualifications are required for the competent technical staff involved in the manufacture of drugs by way of basic or semi-basic manufacture?
77. Who is responsible for carrying out the audit of the Authority's accounts?
78. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
79. What is the short title of the rules that govern the Drugs Appellate Board?
80. Which type of research involves intervention, treatment, or medication programs using human subjects?
81. What are "Medicated Cosmetics" under Schedule-I?
82. When a Federal Inspector is not competent to take action under Schedule-IV, what should he do?
83. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?
84. What is the definition of "promotion" for the purposes of Schedule G of 1976 Rules?
85. Who has the authority to establish the Drug Regulatory Authority of Pakistan?
86. What is the purpose of Form 10 in the export of drugs?
87. Who can revoke an order passed under Section 32 of the DRAP Act, 2012?
88. What is the purpose of the criteria regarding medical representatives?
89. Who qualifies as a Federal Inspector according to these rules?
90. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
91. Who has the power to institute a prosecution for a contravention of any provision of the DRAP Act, 2012, and The Drugs Act, 1976?
92. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
93. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
94. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
95. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
96. How long do members, other than ex-officio members, of the Appellate Board hold office for initially?
97. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
98. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
99. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
100. What is the fee for the renewal of registration of a new drug?
